Dongxing Xie

1.4k citations
53 papers · 862 indexed · h-index 17
Topics
Gout, Hyperuricemia, Uric Acid (15 papers)Osteoarthritis Treatment and Mechanisms (13 papers)Total Knee Arthroplasty Outcomes (10 papers)
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Dongxing Xie

51 papers receiving 849 citations

Peers

Dongxing Xie
Comparison fields: 5 of 112
  • Rheumatology 286
  • Surgery 259
  • Pharmacology 159
  • Nephrology 144
  • Orthopedics and Sports Medicine 120
Replace Han‐Hsiang Chen with:
Han‐Hsiang Chen Taiwan
Flavia Tosi Italy
Lawrence J. Leventhal United States
Kaj Anker Jørgensen Denmark
Silvia Finazzi Italy
Changying Xing China
Inmaculada Colina Spain
Hamid Noshad Iran
Uğur Erdem Işıkan Türkiye
Abdullah Uyanık Türkiye
Dongxing Xie relative to Han‐Hsiang Chen Taiwan Han‐Hsiang Chen's profile →
Citations per field
00.5×4.7×
Han‐Hsiang Chen · 1×
Citations per year

Countries citing papers authored by Dongxing Xie

Since Specialization
Citations

This map shows the geographic impact of Dongxing Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongxing Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongxing Xie more than expected).

Fields of papers citing papers by Dongxing Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongxing Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongxing Xie. The network helps show where Dongxing Xie may publish in the future.

Co-authorship network of co-authors of Dongxing Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Dongxing Xie. A scholar is included among the top collaborators of Dongxing Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongxing Xie. Dongxing Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 0
4 4
5 4
6 6
7 10
8 2
9 7
10 3
11 15
12 5
13 8
14 10
15 10
16 12
17 1
18 19
19 23
20 34

About Dongxing Xie

Dongxing Xie is a scholar working on Nephrology, Rheumatology and Orthopedics and Sports Medicine, having authored 53 papers that have together received 862 indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (15 papers), Osteoarthritis Treatment and Mechanisms (13 papers) and Total Knee Arthroplasty Outcomes (10 papers). The work is most often cited by research in Nephrology (144 citations), Rheumatology (286 citations) and Orthopedics and Sports Medicine (120 citations). Dongxing Xie has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yilun Wang, Chao Zeng, Guanghua Lei, Jie Wei, Tuo Yang, Huizhong Long, Jiatian Li, Xiaoxiao Li, Hui Li and Ziying Wu. Their work appears in journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026